In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.

The quality of indoor air dramatically affects the health of animals and humans during livestock production. Airborne transmission has been suspected of being responsible for epidemics of highly infectious diseases in livestock production, and due to the COVID-19 pandemic, there has been increasing concern about the role of wild animals in the epidemiology of most zoonoses.

Download this whitepaper to learn how an archive strategy can reduce backup and recovery times whilst removing manual intervention and variability.

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.

Since the dawn of the digital age in the 1980s we have seen an increase in cybertheft; each evolution in data storage and movement has brought new methods of putting data at risk.

Tandem mass spectrometry (MS/MS) has evolved as one of the most valuable analytical tools available to modern scientists and enables the identification, structural elucidation and quantitation of compounds.

Host Cell Proteins (HCPs) are a heterogeneous, complex group of proteins that derived from the host cell. Regulatory agencies examine each protein drug on a case-by-case basis to determine appropriate maximum acceptable levels of HCPs considering patient risk.

Download this whitepaper to learn more about the analysis of varied particle sizes, sampling techniques and automation options for infrared microscopy.

Development of a manufacturing process for a biotherapeutic that ensures consistent quality, purity and safety is a critical step in successfully developing the drug, getting it approved by regulatory agencies, and bringing it to the market.

Cancer immunotherapy relies on activating or enhancing the antitumor immune response and has taken a central position in cancer treatment modalities. However, not all patients respond to immunotherapy.